DUNAD THERAPEUTICS
Dunad Therapeutics is a biopharmaceutical company focusing on the development of next-generation targeted protein degradation therapies.
DUNAD THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2020-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.dunad.co.uk
Status:
Active
Total Funding:
24 M USD
Technology used in webpage:
SPF Euro Microsoft Exchange Online Office 365 Mail GoDaddy DNS DMARC Digital Ocean Elastic Email
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Jacobio Pharmaceuticals
Jacobio Pharmaceuticals is a clinical-stage pharmaceutical company focusing on the development of innovative oncology and other therapies.
MRM Health NV
MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Novartis
Novartis investment in Series A - Dunad Therapeutics
Epidarex Capital
Epidarex Capital investment in Series A - Dunad Therapeutics
BioGeneration Ventures
BioGeneration Ventures investment in Series A - Dunad Therapeutics
Epidarex Capital
Epidarex Capital investment in Seed Round - Dunad Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-28 | Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive Officer |
Official Site Inspections
http://www.dunad.co.uk Semrush global rank: 4.4 M Semrush visits lastest month: 2.54 K
- Host name: 764520.cloudwaysapps.com
- IP address: 209.97.186.50
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
More informations about "Dunad Therapeutics"
Dunad Therapeutics - LinkedIn
Dunad Therapeutics | 4,228 followers on LinkedIn. Tunable covalent chemistry with a deep …See details»
Dunad Therapeutics Ltd. - Life-Sciences-Europe.com
Aug 14, 2020 Organisation › Details Dunad Therapeutics Ltd. https://www.dunad.co.uk. …See details»
DUNAD THERAPEUTICS LTD. - Companies House
GOV.UK Find and update company information Companies House does not verify the …See details»
Dunad Therapeutics - businessweekly.co.uk
6 days ago In 2021, Dunad entered a strategic collaboration with Novartis to develop next …See details»
Dunad Therapeutics - Crunchbase Company Profile
Dunad Therapeutics closed its last funding round on Nov 2, 2021 from a Series A round. Who are Dunad Therapeutics 's competitors? Alternatives and possible competitors to Dunad Therapeutics may include Aura Biosciences , Mirum …See details»
DUNAD Therapeutics Emerges to Develop Next-Generation Small …
Mar 23, 2021 New UK company backed by Epidarex Capital emerges from stealth. …See details»
Dunad Therapeutics enters Strategic Collaboration with Novartis …
Nov 2, 2021 Dunad was founded in 2020 and is headquartered in Cambridge, UK with …See details»
Dunad Therapeutics Emerges To Develop Next-generation Small …
Mar 23, 2021 Dunad Therapeutics Emerges To Develop Next-generation Small Molecule …See details»
Dunad Therapeutics - VentureRadar
" Dunad Therapeutics is a biopharmaceutical company focusing on the development of next …See details»
Dunad Therapeutics Appoints Industry Veteran Pearl Huang as …
Dr. Huang brings more than 30 years of biopharma experience, most recently as Chief …See details»
Novartis Links with UK’s Dunad in $1.3 Billion Protein ... - BioSpace
Nov 2, 2021 Diana Kraskouskaya, Ph.D., co-founder and chief operating officer of Dunad, …See details»
Novartis signs $1.3bn deal with UK-based Dunad - PharmaTimes
Nov 3, 2021 Novartis and Cambridge, UK-based Dunad Therapeutics have entered into a …See details»
Dunad Therapeutics Emerges To Develop Next-generation Small …
Mar 23, 2021 Dunad was founded in 2020 and is headquartered in Cambridge, UK with …See details»
UK biotech Dunad inks $1.3bn Novartis deal for its protein degraders
5 days ago In only its second year of operations, Cambridge, UK startup Dunad Therapeutics …See details»
Epidarex’s company-building model continues to deliver with …
Nov 2, 2021 Dunad’s proprietary platform aims to generate novel oral covalent and protein …See details»
DUNAD THERAPEUTICS EMERGES TO DEVELOP NEXT …
Cambridge, UK, March 23, 2021 - Dunad Therapeutics (“Dunad”) emerges today to develop …See details»
Dunad Therapeutics enters Strategic Collaboration with Novartis
Cambridge, UK, November 2, 2021 – Dunad Therapeutics (“Dunad”), a biopharmaceutical …See details»
Dunad, Novartis partner to develop oral protein degrader therapies
The collaboration will see Dunad handle programme execution, right up to lead optimisation, …See details»